HOUSE_OVERSIGHT_028420.jpg
The document is JSON code describing an article about the pharmaceutical company Celgene. The article alleges that Celgene used a federal safety program (REMS) to block generic competition for its drugs, Revlimid and Thalomid, leading to lawsuits from companies like Mylan. The text also mentions a patient paying high costs and a professor criticizing Celgene's actions.
Entities connected to both Elaine Kodish and Revlimid
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein relationship